324 related articles for article (PubMed ID: 8011732)
1. [Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus viridans].
Gavaldà J; Pahissa A; Almirante B
Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):174-6. PubMed ID: 8011732
[No Abstract] [Full Text] [Related]
2. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
Martínez F; Martín Luengo F; Valdés M
Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
[TBL] [Abstract][Full Text] [Related]
3. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.
Levy CS; Kogulan P; Gill VJ; Croxton MB; Kane JG; Lucey DR
Clin Infect Dis; 2001 Aug; 33(4):577-9. PubMed ID: 11462199
[TBL] [Abstract][Full Text] [Related]
4. Penicillin tolerance in experimental streptococcal endocarditis.
Pulliam L; Inokuchi S; Hadley WK; Mills J
Lancet; 1979 Nov; 2(8149):957. PubMed ID: 91047
[No Abstract] [Full Text] [Related]
5. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
Martínez F; Martín-Luengo F; García A; Valdés M
Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
[TBL] [Abstract][Full Text] [Related]
6. Bacterial endocarditis due to penicillin-resistant Streptococcus viridans.
McCarthy VP; Cho CT; Diehl AM; Ramsey BW
Clin Pediatr (Phila); 1979 May; 18(5):263-6. PubMed ID: 109241
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
Durack DT; Pelletier LL; Petersdorf RG
J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
[TBL] [Abstract][Full Text] [Related]
8. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
Hsu RB; Lin FY
Cardiology; 2006; 105(4):234-9. PubMed ID: 16534200
[TBL] [Abstract][Full Text] [Related]
9. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
Enzler MJ; Rouse MS; Henry NK; Geraci JE; Wilson WR
J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
[TBL] [Abstract][Full Text] [Related]
11. Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis.
Parrillo JE; Borst GC; Mazur MH; Iannini P; Klempner MS; Moellering RC; Anderson SE
N Engl J Med; 1979 Feb; 300(6):296-300. PubMed ID: 252640
[No Abstract] [Full Text] [Related]
12. Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.
Savitch CB; Barry AL; Hoeprich PD
Arch Intern Med; 1978 Jun; 138(6):931-4. PubMed ID: 246729
[TBL] [Abstract][Full Text] [Related]
13. A patient with penicillin-resistant viridans group streptococcal endocarditis and unusual reactions to vancomycin.
Apiwattanakul N; Wanitkun S; Chongtrakool P; Sirinavin S
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1088-91. PubMed ID: 19062700
[TBL] [Abstract][Full Text] [Related]
14. Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime.
Lonks JR; Dickinson BP; Runarsdottir V
N Engl J Med; 1999 Oct; 341(16):1239. PubMed ID: 10523160
[No Abstract] [Full Text] [Related]
15. Vancomycin therapy for infective endocarditis.
Geraci JE; Wilson WR
Rev Infect Dis; 1981; 3 suppl():S250-8. PubMed ID: 7342289
[TBL] [Abstract][Full Text] [Related]
16. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
Martínez F; Martín-Luengo F; Garcia A; Valdés M
J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of Streptococcus viridans: therapeutic considerations in infective endocarditis.
Fisher J; Levene DL
Can Med Assoc J; 1975 May; 112(10):1217-9. PubMed ID: 1125890
[TBL] [Abstract][Full Text] [Related]
18. Relatively penicillin-resistant Streptococcus sanguis endocarditis in an adolescent.
Boenning DA; Nelson LP; Campos JM
Pediatr Infect Dis J; 1988 Mar; 7(3):205-7. PubMed ID: 3357720
[No Abstract] [Full Text] [Related]
19. [Acute infective endocarditis due to Streptococcus suis serotype 2 in Spain].
Aspiroz C; Vela AI; Pascual MS; Aldea MJ
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):370-1. PubMed ID: 19442415
[No Abstract] [Full Text] [Related]
20. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
Henry NK; Wilson WR; Roberts RB; Acar JF; Geraci JE
Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
